322 related articles for article (PubMed ID: 15055561)
1. Leukotriene generation and clinical implications.
Arm JP
Allergy Asthma Proc; 2004; 25(1):37-42. PubMed ID: 15055561
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological modulation of the leukotriene pathway in allergic airway disease.
Montuschi P; Sala A; Dahlén SE; Folco G
Drug Discov Today; 2007 May; 12(9-10):404-12. PubMed ID: 17467577
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene modifiers in pediatric asthma management.
Bisgaard H
Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
[TBL] [Abstract][Full Text] [Related]
4. Leukotrienes, antileukotrienes and asthma.
Montuschi P
Mini Rev Med Chem; 2008 Jun; 8(7):647-56. PubMed ID: 18537720
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene modifiers for asthma treatment.
Montuschi P; Peters-Golden ML
Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
[TBL] [Abstract][Full Text] [Related]
6. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
Devillier P; Baccard N; Advenier C
Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
[TBL] [Abstract][Full Text] [Related]
7. Treatment of asthma with drugs modifying the leukotriene pathway.
Drazen JM; Israel E; O'Byrne PM
N Engl J Med; 1999 Jan; 340(3):197-206. PubMed ID: 9895400
[No Abstract] [Full Text] [Related]
8. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
Fal AM; Kopeć A
Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic properties of leukotriene receptor antagonists.
Nicosia S
Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
[TBL] [Abstract][Full Text] [Related]
10. Targeting cysteinyl leukotrienes in patients with rhinitis, sinusitis and paranasal polyps.
Parnes SM
Am J Respir Med; 2002; 1(6):403-8. PubMed ID: 14720027
[TBL] [Abstract][Full Text] [Related]
11. The role of leukotriene inhibitors in allergic rhinitis and paranasal sinusitis.
Parnes SM
Expert Opin Pharmacother; 2002 Jan; 3(1):33-8. PubMed ID: 11772331
[TBL] [Abstract][Full Text] [Related]
12. Discovery of leukotrienes and development of antileukotriene agents.
Leff AR;
Ann Allergy Asthma Immunol; 2001 Jun; 86(6 Suppl 1):4-8. PubMed ID: 11426915
[TBL] [Abstract][Full Text] [Related]
13. [Role of peptide-leukotrienes in bronchial asthma].
Kohno S
Nihon Yakurigaku Zasshi; 1998 Apr; 111(4):223-31. PubMed ID: 9618707
[TBL] [Abstract][Full Text] [Related]
14. Leukotrienes in respiratory disease.
McMillan RM
Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
Bisgaard H
Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
[TBL] [Abstract][Full Text] [Related]
16. Antileukotriene drugs: clinical application, effectiveness and safety.
Riccioni G; Bucciarelli T; Mancini B; Di Ilio C; D'Orazio N
Curr Med Chem; 2007; 14(18):1966-77. PubMed ID: 17691939
[TBL] [Abstract][Full Text] [Related]
17. [The role of leukotrienes and the effect of leukotriene receptor antagonists in allergic rhinitis].
Kupryś I; Kuna P
Pol Merkur Lekarski; 2000 Oct; 9(52):717-20. PubMed ID: 11144066
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene modifiers in the treatment of cardiovascular diseases.
Riccioni G; Capra V; D'Orazio N; Bucciarelli T; Bazzano LA
J Leukoc Biol; 2008 Dec; 84(6):1374-8. PubMed ID: 18794213
[TBL] [Abstract][Full Text] [Related]
19. Antileukotrienes in clinical development for asthma.
Centanni S; Santus P
Expert Opin Investig Drugs; 2002 Jan; 11(1):49-58. PubMed ID: 11772320
[TBL] [Abstract][Full Text] [Related]
20. Cough, asthma, and cysteinyl-leukotrienes.
Niimi A
Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
